Repligen Corp.
RGEN
Market Cap$6.94B
Close$
$59.04
52.5% downside
Current Fair Value
52.5% downsideOvervalued by 52.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.94 Billion |
|---|---|
| Enterprise Value | $6.77 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.46 |
| Beta | 1.11 |
| Outstanding Shares | 56,123,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -273.32 |
|---|---|
| PEG | -153.19 |
| Price to Sales | 11.31 |
| Price to Book Ratio | 3.55 |
| Enterprise Value to Revenue | 10.49 |
| Enterprise Value to EBIT | 332.93 |
| Enterprise Value to Net Income | -1035 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Repligen Corp.
CEO: Anthony Hunt